| Title |
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2012
|
| DOI | 10.1002/14651858.cd000525.pub3 |
| Pubmed ID | |
| Authors |
Kaushadh Jayakody, Roger Carl Gibson, Ajit Kumar, Shalmini Gunadasa |
| Abstract |
Medication used for acute aggression in psychiatry must have rapid onset of effect, low frequency of administration and low levels of adverse effects. Zuclopenthixol acetate is said to have these properties. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 33% |
| India | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 50% |
| Practitioners (doctors, other healthcare professionals) | 3 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Italy | 1 | <1% |
| Israel | 1 | <1% |
| South Africa | 1 | <1% |
| Canada | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 229 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 41 | 17% |
| Student > Bachelor | 31 | 13% |
| Student > Ph. D. Student | 24 | 10% |
| Researcher | 23 | 10% |
| Student > Doctoral Student | 13 | 6% |
| Other | 44 | 19% |
| Unknown | 60 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 30% |
| Psychology | 36 | 15% |
| Nursing and Health Professions | 24 | 10% |
| Social Sciences | 10 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 26 | 11% |
| Unknown | 62 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2016.
All research outputs
#4,210,282
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,477
of 11,842 outputs
Outputs of similar age
#26,553
of 174,458 outputs
Outputs of similar age from Cochrane database of systematic reviews
#88
of 181 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 181 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.